| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |